Design
Review
Authors
Loading...
Endothelin antagonists may mitigate renal disease progression; leaves open confirmation of clinical efficacy in randomized trials.
Key points are not available for this paper at this time.
David P. Brooks (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: